Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 28, 2017; 23(16): 2957-2963
Published online Apr 28, 2017. doi: 10.3748/wjg.v23.i16.2957
Table 3 Characteristics after treatment (12 mo)
CharacteristicObservation groupControl groupP value
Leukocytes (× 109/L)5.18 ± 0.995.89 ± 0.950.029
Neutrophils (× 109/L)3.52 ± 0.743.98 ± 0.540.018
Hemoglobin (g/L)125.54 ± 12.38118.69 ± 10.360.045
Platelets (× 109/L)120.65 ± 19.10105.23 ± 20.310.009
Blood urea nitrogen (mmol/L)4.39 ± 0.875.74 ± 2.090.049
Sodium (mmol/L)134.12 ± 5.43128.72 ± 5.360.005
Albumin (g/L)38.77 ± 4.7634.10 ± 4.550.005
Total bilirubin (μmol/L)37.71 ± 14.5347.44 ± 13.440.015
Alanine aminotransferase (U/L)49.23 ± 18.4158.77 ± 15.000.040
Aspartate aminotransferase (U/L)42.10 ± 11.9651.31 ± 17.610.042
Gamma glutamyl transpeptidase (U/L)53.75 ± 15.9566.38 ± 17.870.022
Prothrombin time (s)16.41 ± 1.8118.23 ± 2.770.047
International normalized ratio1.50 ± 0.171.66 ± 0.250.047
Maddrey’s discriminant function13.90 ± 8.6522.24 ± 12.770.017
Child-Turcotte-Pugh7.46 ± 1.359.15 ± 1.630.001